{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T17:46:53Z","timestamp":1792432013401,"version":"4.5.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,9,2]],"date-time":"2015-09-02T00:00:00Z","timestamp":1441152000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s40257-015-0153-5","type":"journal-article","created":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T15:14:47Z","timestamp":1441120487000},"page":"463-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Alternative Systemic Treatments for Vitiligo: A Review"],"prefix":"10.1007","volume":"16","author":[{"given":"Brandon E.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Elbuluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euphemia W.","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Orlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,2]]},"reference":[{"issue":"2","key":"153_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1056\/NEJMcp0804388","volume":"360","author":"A Taieb","year":"2009","unstructured":"Taieb A, Picardo M. Clinical practice. Vitiligo. N Engl J Med. 2009;360(2):160\u20139.","journal-title":"N Engl J Med."},{"issue":"2","key":"153_CR2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1529-8019.2008.00178.x","volume":"21","author":"T Lotti","year":"2008","unstructured":"Lotti T, Gori A, Zanieri F, Colucci R, Moretti S. Vitiligo: new and emerging treatments. Dermatol Ther. 2008;21(2):110\u20137.","journal-title":"Dermatol Ther."},{"key":"153_CR3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-5945-8-2","volume":"8","author":"O Szczurko","year":"2008","unstructured":"Szczurko O, Boon HS. A systematic review of natural health product treatment for vitiligo. BMC Dermatol. 2008;8:2.","journal-title":"BMC Dermatol."},{"issue":"1","key":"153_CR4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2133.2009.09077.x","volume":"161","author":"P Kostopoulou","year":"2009","unstructured":"Kostopoulou P, Jouary T, Quintard B, Ezzedine K, Marques S, Boutchnei S, et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009;161(1):128\u201333.","journal-title":"Br J Dermatol."},{"key":"153_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1477-7525-1-58","volume":"1","author":"D Parsad","year":"2003","unstructured":"Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58.","journal-title":"Health Qual Life Outcomes."},{"issue":"5","key":"153_CR6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1346-8138.2010.01139.x","volume":"38","author":"R Yaghoobi","year":"2011","unstructured":"Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the published work. J Dermatol. 2011;38(5):419\u201331.","journal-title":"J Dermatol."},{"issue":"6","key":"153_CR7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S0738-081X(97)00130-2","volume":"15","author":"SK Hann","year":"1997","unstructured":"Hann SK, Park YK, Chun WH. Clinical features of vitiligo. Clin Dermatol. 1997;15(6):891\u20137.","journal-title":"Clin Dermatol."},{"issue":"7","key":"153_CR8","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/jid.2011.463","volume":"132","author":"JE Harris","year":"2012","unstructured":"Harris JE, Harris TH, Weninger W, Wherry EJ, Hunter CA, Turka LA. A mouse model of vitiligo with focused epidermal depigmentation requires IFN-gamma for autoreactive CD8(+) T-cell accumulation in the skin. J Invest Dermatol. 2012;132(7):1869\u201376.","journal-title":"J Invest Dermatol."},{"issue":"7","key":"153_CR9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jgg.2011.05.005","volume":"38","author":"RA Spritz","year":"2011","unstructured":"Spritz RA. Recent progress in the genetics of generalized vitiligo. J Genet Genomics. 2011;38(7):271\u20138.","journal-title":"J Genet Genomics."},{"issue":"7","key":"153_CR10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/thy.2010.1643","volume":"20","author":"RA Spritz","year":"2010","unstructured":"Spritz RA. Shared genetic relationships underlying generalized vitiligo and autoimmune thyroid disease. Thyroid. 2010;20(7):745\u201354.","journal-title":"Thyroid."},{"issue":"26","key":"153_CR11","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1056\/NEJMicm990602","volume":"350","author":"F Egli","year":"2004","unstructured":"Egli F, Walter R. Images in clinical medicine. Vitiligo and pernicious anemia. N Engl J Med. 2004;350(26):2698.","journal-title":"N Engl J Med."},{"issue":"Suppl 1","key":"153_CR12","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ymgme.2005.07.023","volume":"86","author":"KU Schallreuter","year":"2005","unstructured":"Schallreuter KU, Chavan B, Rokos H, Hibberts N, Panske A, Wood JM. Decreased phenylalanine uptake and turnover in patients with vitiligo. Mol Genet Metab. 2005;86(Suppl 1):S27\u201333.","journal-title":"Mol Genet Metab."},{"issue":"4","key":"153_CR13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3109\/09546634.2014.952610","volume":"26","author":"BH Xiao","year":"2015","unstructured":"Xiao BH, Wu Y, Sun Y, Chen HD, Gao XH. Treatment of vitiligo with NB-UVB: a systematic review. J Dermatolog Treat. 2015;26(4):340\u20136.","journal-title":"J Dermatolog Treat."},{"issue":"3","key":"153_CR14","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000247142","volume":"188","author":"AH Siddiqui","year":"1994","unstructured":"Siddiqui AH, Stolk LM, Bhaggoe R, Hu R, Schutgens RB, Westerhof W. L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology. 1994;188(3):215\u20138.","journal-title":"Dermatology."},{"issue":"8","key":"153_CR15","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-4362.1989.tb04613.x","volume":"28","author":"C Antoniou","year":"1989","unstructured":"Antoniou C, Schulpis H, Michas T, Katsambas A, Frajis N, Tsagaraki S, et al. Vitiligo therapy with oral and topical phenylalanine with UVA exposure. Int J Dermatol. 1989;28(8):545\u20137.","journal-title":"Int J Dermatol."},{"issue":"2","key":"153_CR16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/BF00414110","volume":"277","author":"RH Cormane","year":"1985","unstructured":"Cormane RH, Siddiqui AH, Westerhof W, Schutgens RB. Phenylalanine and UVA light for the treatment of vitiligo. Arch Dermatol Res. 1985;277(2):126\u201330.","journal-title":"Arch Dermatol Res."},{"issue":"7","key":"153_CR17","first-page":"519","volume":"62","author":"B Thiele","year":"1987","unstructured":"Thiele B, Steigleder GK. Repigmentation treatment of vitiligo with l-phenylalanine and UVA irradiation [in German]. Z Hautkr. 1987;62(7):519\u201323.","journal-title":"Z Hautkr."},{"issue":"2","key":"153_CR18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archderm.135.2.216","volume":"135","author":"F Camacho","year":"1999","unstructured":"Camacho F, Mazuecos J. Treatment of vitiligo with oral and topical phenylalanine: 6\u00a0years of experience. Arch Dermatol. 1999;135(2):216\u20137.","journal-title":"Arch Dermatol."},{"issue":"3","key":"153_CR19","first-page":"149","volume":"89","author":"GR Kuiters","year":"1986","unstructured":"Kuiters GR, Hup JM, Siddiqui AH, Cormane RH. Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the Caribbean island of Curacao NA. J Trop Med Hyg. 1986;89(3):149\u201355.","journal-title":"J Trop Med Hyg."},{"issue":"2","key":"153_CR20","first-page":"127","volume":"1","author":"F Camacho","year":"2002","unstructured":"Camacho F, Mazuecos J. Oral and topical l-phenylalanine, clobetasol propionate, and UVA\/sunlight\u2013a new study for the treatment of vitiligo. J Drugs Dermatol. 2002;1(2):127\u201331.","journal-title":"J Drugs Dermatol."},{"issue":"4","key":"153_CR21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.1989.tb00921.x","volume":"6","author":"CH Schulpis","year":"1989","unstructured":"Schulpis CH, Antoniou C, Michas T, Strarigos J. Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo. Pediatr Dermatol. 1989;6(4):332\u20135.","journal-title":"Pediatr Dermatol."},{"issue":"2","key":"153_CR22","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1006\/bbrc.1997.8107","volume":"243","author":"KU Schallreuter","year":"1998","unstructured":"Schallreuter KU, Zschiesche M, Moore J, Panske A, Hibberts NA, Herrmann FH, et al. In vivo evidence for compromised phenylalanine metabolism in vitiligo. Biochem Biophys Res Commun. 1998;243(2):395\u20139.","journal-title":"Biochem Biophys Res Commun."},{"issue":"3605","key":"153_CR23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1126\/science.143.3605.479","volume":"143","author":"WL Ryan","year":"1964","unstructured":"Ryan WL, Carver MJ. Inhibition of antibody synthesis by l-phenylalanine. Science. 1964;143(3605):479\u201380.","journal-title":"Science."},{"issue":"3","key":"153_CR24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5070\/D39WW9F65D","volume":"13","author":"P Emanuel","year":"2007","unstructured":"Emanuel P, Scheinfeld N. A review of DNA repair and possible DNA-repair adjuvants and selected natural anti-oxidants. Dermatol Online J. 2007;13(3):10.","journal-title":"Dermatol Online J."},{"issue":"3","key":"153_CR25","first-page":"13","volume":"7","author":"M Nestor","year":"2014","unstructured":"Nestor M, Bucay V, Callender V, Cohen JL, Sadick N, Waldorf H. Polypodium leucotomos as an adjunct treatment of pigmentary disorders. J Clin Aesthet Dermatol. 2014;7(3):13\u20137.","journal-title":"J Clin Aesthet Dermatol."},{"issue":"7","key":"153_CR26","first-page":"479","volume":"28","author":"A Mohammad","year":"1989","unstructured":"Mohammad A. Vitiligo repigmentation with anapsos (Polypodium leucotomos). Int J Dermatol. 1989;28(7):479.","journal-title":"Int J Dermatol."},{"issue":"7","key":"153_CR27","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","volume":"21","author":"MA Middelkamp-Hup","year":"2007","unstructured":"Middelkamp-Hup MA, Bos JD, Rius-Diaz F, Gonzalez S, Westerhof W. Treatment of vitiligo vulgaris with narrow-band UVB and oral Polypodium leucotomos extract: a randomized double-blind placebo-controlled study. J Eur Acad Dermatol Venereol. 2007;21(7):942\u201350.","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"153_CR28","doi-asserted-by":"crossref","unstructured":"Pacifico A, Vidolin AP, Leone G, Iacovelli P. Combined treatment of narrowband ultraviolet B light (NBUVB) phototherapy and oral Polypodium leucotomos extract versus NB UVB phototherapy alone in the treatment of patients with vitiligo. J Am Acad Dermatol. 2009;3(Suppl 1):AB154.","DOI":"10.1016\/j.jaad.2008.11.676"},{"key":"153_CR29","doi-asserted-by":"crossref","unstructured":"Reyes E, Jaen P, de las Heras E, Carrion F, Alvarez-Mon M, de Eusebio E, et al. Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study. J Dermatol Sci. 2006;41(3):213\u20136.","DOI":"10.1016\/j.jdermsci.2005.12.006"},{"issue":"4","key":"153_CR30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1163\/156856001320290624","volume":"9","author":"A Brieva","year":"2002","unstructured":"Brieva A, Guerrero A, Pivel JP. Immunomodulatory properties of a hydrophilic extract of Polypodium leucotomos. Inflammopharmacology. 2002;9(4):361\u201371.","journal-title":"Inflammopharmacology."},{"issue":"6","key":"153_CR31","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.jaad.2004.06.027","volume":"51","author":"MA Middelkamp-Hup","year":"2004","unstructured":"Middelkamp-Hup MA, Pathak MA, Parrado C, Goukassian D, Rius-Diaz F, Mihm MC, et al. Oral Polypodium leucotomos extract decreases ultraviolet-induced damage of human skin. J Am Acad Dermatol. 2004;51(6):910\u20138.","journal-title":"J Am Acad Dermatol."},{"issue":"3","key":"153_CR32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/ijd.12611","volume":"54","author":"N El-Haj","year":"2015","unstructured":"El-Haj N, Goldstein N. Sun protection in a pill: the photoprotective properties of Polypodium leucotomos extract. Int J Dermatol. 2015;54(3):362\u20136.","journal-title":"Int J Dermatol."},{"key":"153_CR33","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/1874372201105010006","volume":"5","author":"S Gonzalez","year":"2011","unstructured":"Gonzalez S, Gilaberte Y, Philips N, Juarranz A. Current trends in photoprotection: a new generation of oral photoprotectors. Open Dermatol J. 2011;5:6\u201314.","journal-title":"Open Dermatol J."},{"issue":"3","key":"153_CR34","first-page":"225","volume":"11","author":"A Hofer","year":"2001","unstructured":"Hofer A, Kerl H, Wolf P. Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol. 2001;11(3):225\u20139.","journal-title":"Eur J Dermatol."},{"issue":"4 Pt 1","key":"153_CR35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(88)70092-4","volume":"18","author":"B Ortel","year":"1988","unstructured":"Ortel B, Tanew A, Honigsmann H. Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol. 1988;18(4 Pt 1):693\u2013701.","journal-title":"J Am Acad Dermatol."},{"issue":"5","key":"153_CR36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/1523-1747.ep13083852","volume":"90","author":"P Morliere","year":"1988","unstructured":"Morliere P, Honigsmann H, Averbeck D, Dardalhon M, Huppe G, Ortel B, et al. Phototherapeutic, photobiologic, and photosensitizing properties of khellin. J Invest Dermatol. 1988;90(5):720\u20134.","journal-title":"J Invest Dermatol."},{"issue":"2","key":"153_CR37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000249932","volume":"165","author":"A Abdel-Fattah","year":"1982","unstructured":"Abdel-Fattah A, Aboul-Enein MN, Wassel GM, El-Menshawi BS. An approach to the treatment of vitiligo by khellin. Dermatologica. 1982;165(2):136\u201340.","journal-title":"Dermatologica."},{"issue":"1","key":"153_CR38","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1468-3083.2010.03701.x","volume":"25","author":"J Leeuw de","year":"2011","unstructured":"de Leeuw J, Assen YJ, van der Beek N, Bjerring P, Martino Neumann HA. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation. J Eur Acad Dermatol Venereol. 2011;25(1):74\u201381.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"2","key":"153_CR39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2230.2004.01462.x","volume":"29","author":"S Valkova","year":"2004","unstructured":"Valkova S, Trashlieva M, Christova P. Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. Clin Exp Dermatol. 2004;29(2):180\u20134.","journal-title":"Clin Exp Dermatol."},{"key":"153_CR40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6882-11-21","volume":"11","author":"O Szczurko","year":"2011","unstructured":"Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med. 2011;11:21.","journal-title":"BMC Complement Altern Med."},{"issue":"3","key":"153_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00403-009-0979-x","volume":"302","author":"S Trompezinski","year":"2010","unstructured":"Trompezinski S, Bonneville M, Pernet I, Denis A, Schmitt D, Viac J. Gingko biloba extract reduces VEGF and CXCL-8\/IL-8 levels in keratinocytes with cumulative effect with epigallocatechin-3-gallate. Arch Dermatol Res. 2010;302(3):183\u20139.","journal-title":"Arch Dermatol Res."},{"issue":"7","key":"153_CR42","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11606-005-0114-4","volume":"20","author":"S Bent","year":"2005","unstructured":"Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with Ginkgo biloba: a case report and systematic review of the literature: a case report and systematic review of the literature. J Gen Intern Med. 2005;20(7):657\u201361.","journal-title":"J Gen Intern Med."},{"issue":"1","key":"153_CR43","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2230.2011.04142.x","volume":"37","author":"AS Karadag","year":"2012","unstructured":"Karadag AS, Tutal E, Ertugrul DT, Akin KO, Bilgili SG. Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo. Clin Exp Dermatol. 2012;37(1):62\u20134.","journal-title":"Clin Exp Dermatol."},{"issue":"3","key":"153_CR44","first-page":"720","volume":"159","author":"OG Shaker","year":"2008","unstructured":"Shaker OG, El-Tahlawi SM. Is there a relationship between homocysteine and vitiligo? A pilot study. Br J Dermatol. 2008;159(3):720\u20134.","journal-title":"Br J Dermatol."},{"issue":"7713","key":"153_CR45","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0140-6736(71)91889-7","volume":"1","author":"J Howitz","year":"1971","unstructured":"Howitz J, Schwartz M. Vitiligo, achlorhydria, and pernicious anaemia. Lancet. 1971;1(7713):1331\u20134.","journal-title":"Lancet."},{"key":"153_CR46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/1110-6530.137315","volume":"34","author":"HHSJ Sabry","year":"2014","unstructured":"Sabry HHSJ, Hashim HM. Serum levels of homocysteine, vitamin B12, and folic acid in vitiligo. Egypt J Dermatol Venereol. 2014;34:65\u20139.","journal-title":"Egypt J Dermatol Venereol."},{"issue":"1","key":"153_CR47","first-page":"39","volume":"50","author":"LF Montes","year":"1992","unstructured":"Montes LF, Diaz ML, Lajous J, Garcia NJ. Folic acid and vitamin B12 in vitiligo: a nutritional approach. Cutis. 1992;50(1):39\u201342.","journal-title":"Cutis."},{"issue":"6","key":"153_CR48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2340\/000155555577460462","volume":"77","author":"L Juhlin","year":"1997","unstructured":"Juhlin L, Olsson MJ. Improvement of vitiligo after oral treatment with vitamin B12 and folic acid and the importance of sun exposure. Acta Derm Venereol. 1997;77(6):460\u20132.","journal-title":"Acta Derm Venereol."},{"issue":"1","key":"153_CR49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-4632.2005.02447.x","volume":"45","author":"P Don","year":"2006","unstructured":"Don P, Iuga A, Dacko A, Hardick K. Treatment of vitiligo with broadband ultraviolet B and vitamins. Int J Dermatol. 2006;45(1):63\u20135.","journal-title":"Int J Dermatol."},{"issue":"5","key":"153_CR50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/000155502320624113","volume":"82","author":"M Tjioe","year":"2002","unstructured":"Tjioe M, Gerritsen MJ, Juhlin L, van de Kerkhof PC. Treatment of vitiligo vulgaris with narrow band UVB (311\u00a0nm) for one year and the effect of addition of folic acid and vitamin B12. Acta Derm Venereol. 2002;82(5):369\u201372.","journal-title":"Acta Derm Venereol."},{"issue":"2","key":"153_CR51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/jcla.20442","volume":"25","author":"S Singh","year":"2011","unstructured":"Singh S, Singh U, Pandey SS. Increased level of serum homocysteine in vitiligo. J Clin Lab Anal. 2011;25(2):110\u20132.","journal-title":"J Clin Lab Anal."},{"issue":"2","key":"153_CR52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaad.2010.08.025","volume":"64","author":"JI Silverberg","year":"2011","unstructured":"Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study. J Am Acad Dermatol. 2011;64(2):445\u20137.","journal-title":"J Am Acad Dermatol."},{"issue":"7","key":"153_CR53","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0091270009335769","volume":"49","author":"M Elgoweini","year":"2009","unstructured":"Elgoweini M, Nour El Din N. Response of vitiligo to narrowband ultraviolet B and oral antioxidants. J Clin Pharmacol. 2009;49(7):852\u20135.","journal-title":"J Clin Pharmacol."},{"issue":"2","key":"153_CR54","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0749.1998.tb00714.x","volume":"11","author":"S Passi","year":"1998","unstructured":"Passi S, Grandinetti M, Maggio F, Stancato A, De Luca C. Epidermal oxidative stress in vitiligo. Pigment Cell Res. 1998;11(2):81\u20135.","journal-title":"Pigment Cell Res."},{"issue":"10","key":"153_CR55","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1007\/s00403-009-0964-4","volume":"301","author":"R Khan","year":"2009","unstructured":"Khan R, Satyam A, Gupta S, Sharma VK, Sharma A. Circulatory levels of antioxidants and lipid peroxidation in Indian patients with generalized and localized vitiligo. Arch Dermatol Res. 2009;301(10):731\u20137.","journal-title":"Arch Dermatol Res."},{"issue":"6","key":"153_CR56","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2230.2007.02514.x","volume":"32","author":"ML Dell\u2019Anna","year":"2007","unstructured":"Dell\u2019Anna ML, Mastrofrancesco A, Sala R, Venturini M, Ottaviani M, Vidolin AP, et al. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial. Clin Exp Dermatol. 2007;32(6):631\u20136.","journal-title":"Clin Exp Dermatol."},{"issue":"1","key":"153_CR57","first-page":"24","volume":"12","author":"M Akyol","year":"2002","unstructured":"Akyol M, Celik VK, Ozcelik S, Polat M, Marufihah M, Atalay A. The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA. Eur J Dermatol. 2002;12(1):24\u20136.","journal-title":"Eur J Dermatol."},{"issue":"3","key":"153_CR58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.4103\/0378-6323.16243","volume":"71","author":"P Shameer","year":"2005","unstructured":"Shameer P, Prasad PV, Kaviarasan PK. Serum zinc level in vitiligo: a case control study. Indian J Dermatol Venereol Leprol. 2005;71(3):206\u20137.","journal-title":"Indian J Dermatol Venereol Leprol."},{"issue":"5","key":"153_CR59","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4103\/0019-5154.87116","volume":"56","author":"N Bagherani","year":"2011","unstructured":"Bagherani N, Yaghoobi R, Omidian M. Hypothesis: zinc can be effective in treatment of vitiligo. Indian J Dermatol. 2011;56(5):480\u20134.","journal-title":"Indian J Dermatol."},{"key":"153_CR60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-5945-11-7","volume":"11","author":"R Yaghoobi","year":"2011","unstructured":"Yaghoobi R, Omidian M, Bagherani N. Original article title: \u201cComparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial\u201d. BMC Dermatol. 2011;11:7.","journal-title":"BMC Dermatol."},{"issue":"7","key":"153_CR61","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s001050050104","volume":"45","author":"D Greiner","year":"1994","unstructured":"Greiner D, Ochsendorf FR, Milbradt R. Vitiligo therapy with phenylalanine\/UVA. Catamnestic studies after five years [in German]. Hautarzt. 1994;45(7):460\u20133.","journal-title":"Hautarzt."}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0153-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40257-015-0153-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-015-0153-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,13]],"date-time":"2023-08-13T16:21:49Z","timestamp":1691943709000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40257-015-0153-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,2]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["153"],"URL":"https:\/\/doi.org\/10.1007\/s40257-015-0153-5","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,2]]}}}